Literature DB >> 15800355

An antidote to the emerging two tier organ donation policy in Canada: the Public Cadaveric Organ Donation Program.

S Giles1.   

Abstract

In Canada, as in many other countries, there exists an organ procurement/donation crisis. This paper reviews some of the most common kidney procurement and allocation programmes, analyses them in terms of public and private administration, and argues that privately administered living donor models are an inequitable stopgap measure, the good intentions of which are misplaced and opportunistic. Focusing on how to improve the publicly administered equitable cadaveric donation programme, and at the same time offering one possible explanation for its current failure, it is suggested that the simple moral principle of "give and you shall receive", already considered by some, be extended further. This would allow for those who are willing to sign up to be a public cadaveric donor be given a priority for receiving an organ donation should they ever require it. It is argued that this priority may provide the motivation to give that is so far lacking in Canada. This model is called the Public Cadaveric Organ Donation Program.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2005        PMID: 15800355      PMCID: PMC1734127          DOI: 10.1136/jme.2003.002931

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  11 in total

1.  Presumed consent or contracting out.

Authors:  C A Erin; J Harris
Journal:  J Med Ethics       Date:  1999-10       Impact factor: 2.903

2.  Nondirected donation of kidneys from living donors.

Authors:  A J Matas; C A Garvey; C L Jacobs; J P Kahn
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

3.  The failure to give: reducing barriers to organ donation.

Authors:  J F Childress
Journal:  Kennedy Inst Ethics J       Date:  2001-03

4.  Ethical incentives--not payment--for organ donation.

Authors:  Francis L Delmonico; Robert Arnold; Nancy Scheper-Hughes; Laura A Siminoff; Jeffrey Kahn; Stuart J Youngner
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

5.  The case for "presumed consent" in organ donation. International Forum for Transplant Ethics.

Authors:  I Kennedy; R A Sells; A S Daar; R D Guttmann; R Hoffenberg; M Lock; J Radcliffe-Richards; N Tilney
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

6.  Ethics of a paired-kidney-exchange program.

Authors:  L F Ross; D T Rubin; M Siegler; M A Josephson; J R Thistlethwaite; E S Woodle
Journal:  N Engl J Med       Date:  1997-06-12       Impact factor: 91.245

7.  Procurement and allocation of solid organs for transplantation.

Authors:  P J Hauptman; K J O'Connor
Journal:  N Engl J Med       Date:  1997-02-06       Impact factor: 91.245

8.  Organ procurement: let's presume consent.

Authors:  F Moustarah
Journal:  CMAJ       Date:  1998-01-27       Impact factor: 8.262

Review 9.  Kidney transplantation from living unrelated donors.

Authors:  J M Cecka
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

10.  Cadaveric organ donation: ethical considerations for a new approach.

Authors:  I Kleinman; F H Lowy
Journal:  CMAJ       Date:  1989-07-15       Impact factor: 8.262

View more
  3 in total

1.  Compensated living kidney donation: a plea for pragmatism.

Authors:  Faisal Omar; Gunnar Tufveson; Stellan Welin
Journal:  Health Care Anal       Date:  2009-01-29

2.  Advancing a Paradigm Shift to Approaching Health Systems in the Field of Living-Donor Kidney Transplantation: An Opinion Piece.

Authors:  Shaifali Sandal; Anna Horton; Marie-Chantal Fortin
Journal:  Can J Kidney Health Dis       Date:  2022-02-26

3.  Health Professional-Identified Barriers to Living Donor Kidney Transplantation: A Qualitative Study.

Authors:  Shaifali Sandal; Kathleen Charlebois; Julio F Fiore; David Kenneth Wright; Marie-Chantal Fortin; Liane S Feldman; Ahsan Alam; Catherine Weber
Journal:  Can J Kidney Health Dis       Date:  2019-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.